$FRMM Cashflow Statement | Understand Stock

$FRMM

$3.50 +$0.12 (3.4%) Close

$FRMM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Flows from Operating Activities
Net Loss
Net loss from continuing operations
Stock-based compensation
Impairment of goodwill
Amortization of intangibles
Shares issued for services
Impairment of goodwill
Impairment of IP R&D assets
Amortization of intangibles
Bad debt expense (recovery) - related parties
Bad debt expense - related parties
Gain on settlement of liabilities, net
Loss on extinguishment of convertible note payable
Deferred tax liability
Offering costs allocated to warrant liabilities
Change in fair value of derivative liabilities
Change in fair value of accrued issuable equity
Amortization of stock options and restricted stock units
Depreciation and amortization
Loss on asset impairment
Change in fair value of long-term receivable derivative
Change in fair value of preferred stock liability
Deferred tax benefit
Accounts payable – related parties
Change in fair value of cryptocurrency
Change in fair value of available for sale securities
Change in fair value of convertible debt
Non-cash staking and incentive revenue
Loss on make whole provision
Gain on settlement of liabilities
Prepaid expenses and other current assets
Accounts payable
Accounts payable - related parties
Accrued expenses – related parties
Accrued expenses
Accrued issuable equity
Total adjustments
Total adjustments
Net cash used in operating activities from continuing operations
Net cash used in operating activities from discontinued operations
Net cash used in operating activities
Shares issued for cash, net of issuance costs
Offering costs in connection with 2021 sale of stock and warrants
Offering costs in connection with July 2022 sale of common stock and common stock warrants
Offering costs in connection with December 2022 sale of common stock and common stock warrants
Proceeds from loans payable

Cash Flows from Investing Activities
Purchases of marketable securities
Purchases of digital assets
Purchase of non-marketable securities
Sale of digital asset
Net cash used in investing activities from continuing operations
Net cash used in investing activities
Cash Flows from Financing Activities
Offering costs
Offering costs in connection with July 2022 sale of common stock and common stock warrants
Offering costs in connection with December 2022 sale of common stock and common stock warrants
Offering costs in connection with April 2023 sale of common stock and common stock warrants
Offering costs in connection with August 2023 sale of common stock and common stock warrants
Offering costs in connection with the repricing of the August 2023 Offering

Proceeds from exercise of pre-funded warrants from the Amendment to August 2023 Offering
Proceeds from sale of December 2024 Offering stock and warrants
Repayment of loans payable
Repayment of loans payable related parties
Treasury stock purchases
Proceeds from collateralized loan
Repayment of collateralized loan
Proceeds from convertible debt, net
Repayment of convertible debt, net
Repayment of loans payable, net of adjustments (Note 9)
Proceeds from exercise of common stock options
Proceeds from exercise of common stock warrants
Proceeds from exercise of July 2022 pre-funded warrants
Proceeds from exercise of December 2022 pre-funded warrants
Proceeds from exercise of April 2023 pre-funded warrants
Proceeds from exercise of August 2023 pre-funded warrants
Proceeds from the repricing of common shares and pre-funded warrants in the August 2023 Offering
Total proceeds from exercise of common stock warrants

Proceeds from sale of April 2023 Offering stock and warrants
Proceeds from sale of August 2023 Offering stock and warrants
Proceeds from exercise of April 2023 Offering pre-funded warrants
Proceeds from exercise of August 2023 Offering pre-funded warrants
Proceeds from loans payable
Repayment of loans payable, net of adjustments (Note 8)
Repayment of loans payable – related parties
Proceeds from sale
Proceeds from sale of July 2022 common stock and common stock warrants
Proceeds from sale of December 2022 common stock and common stock warrants
Proceeds from sale of April 2023 common stock and common stock warrants
Proceeds from sale of August 2023 common stock and common stock warrants

Payment of offering costs in connection with April 2023 Offering stock and warrants
Payment of offering costs in connection with August 2023 Offering stock and warrants
Payment of offering costs in connection with August 2023 sale of common stock and common stock warrants
Proceeds from shares issued for cash and warrants, net
Net cash provided by financing activities from continuing operations
Net cash used in financing activities from discontinued operations
Net cash provided by financing activities
Effect of Exchange Rate Changes on Cash

Effect of Exchange Rate Changes on Cash
Net Change In Cash, cash equivalents and restricted cash equivalents
Cash, cash equivalents and restricted cash equivalents - Beginning of Period
Cash, cash equivalents and restricted cash equivalents - End of Period
Supplemental Disclosures of Cash Flow Information
Cash paid during the period for interest expense
Common stock issued upon conversion of KBL debt
Common stock issued upon conversion of 180 debt
Common stock issued in connection with repayment of related party loans and convertible notes
Shares and warrants issued for Alpha Settlement
Exchange of common stock equivalents for common stock
Shares issued to settle accounts payable
Reclassification of accrued issuable equity
Non Cash Investing and Financing Activities
Common stock issued for settlement of liabilities
Shares issued for settlement of liabilities
Prepaid expense financed with notes payable
Loan proceeds received in cryptocurrency
Warrants and Series B Convertible Preferred Stock issued for asset acquisition
ETH holdings contributed in exchange for common stock
Deposits into liquid staking protocols (i.e., staking receivables)
Deemed dividend from warrant inducement
Shares issued for non-marketable securities

Comments